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Abstract  
Aim: This study aims to evaluate the algorithm of procalcitonin (PCT) and its role on the duration of antibiotics 
prescription for intra-abdominal infections. 
Materials and Methods: This study is a prospective controlled study that is conducted in groups of 50 
hospitalised patients and 50 controlled group patients.  
Results: The results indicated that the average duration of antibiotic delivery to the PCT group was -10.6 days 
(SD ± 6.6 days), while in the control group -13.2 days (SD ± 4.2 days). These data showed a significant difference 
in the duration of antibiotic therapy and the monitoring role of PCTs in the prediction success of antibiotic 
treatment. The antibiotic delivery was longer in the septic shock 17 (SD ± 11.7) that corresponds to high PCT 
values of 67.8 (SD ± 50.9). Recurrence of the infection after the cessation of antibiotics occurred in 2 cases (4%) 
in the standard group, while it occurred in 3 cases (6%) in the control group. 
Conclusion: The treatment of the intra-abdominal infections based on the PCT algorithm shortens the duration of 
antibiotic treatment and does not pose a risk for the recurrence of the infection. 
 
 
 
 
 
Introduction 
 
Intra-abdominal infections are a group of 
diseases with a relatively high degree of mortality and 
morbidity. Two determinants for the successful 
treatment of intra-abdominal infections are the 
identification of the source of the infection and the 
speed at which the empirical delivery of antibiotics 
begins, circumstances that reduce the risk of 
complications and mortality [1]. Reduction of mortality 
is not possible without effective control of the source 
of infection [2]. The mortality rate of intra-abdominal 
infections was about 90% at the end of the 19th 
century, where management was mostly non-
operative. In recent years, surgical intervention in 
intra-abdominal infections has influenced the control 
of the source of infection by reducing the mortality rate 
about 30% in cases of severe sepsis and septic shock 
[3-5]. Reduction of mortality rate is achieved with the 
earliest diagnostics of these infections and timely and 
adequate treatment [6-8]. 
Antibiotic therapy should start immediately 
after the intraabdominal infection diagnosis, while the 
duration of administration of antibiotics is a matter of 
ongoing discussion and there is still no consensus [8]. 
Treatment protocols recommend empirical 
antimicrobial therapy that is effective against the 
enterococcus, staphylococcus and the candida [6, 7]. 
If the empirical antibiotic is inadequate, it is followed 
by failure of treatment, an extension of hospitalisation 
and death. Non-rational antibiotic delivery leads to 
increased resistance to antibiotics and the 
appearance of intrahospital infections [8]. Therefore it 
is recommended to restrict the use of antibiotics and 
apply the biomarker algorithm in treatment to monitor 
the success of antibiotic therapy and discontinuation 
of their ordination as earliest [9, 10]. In Intensive Care 
Department, the procalcitonin (PCT) serial 
measurement can be used as a guide to facilitate the 
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most rapid interruption of antibiotics [11]. PCT is the 
calcitonin prohormone produced by the C-cell of the 
thyroid gland. The PCT inflammatory processes do 
not happen in thyroid C cells and do not depend on 
the calcium concentration, but its production depends 
on the microbial endotoxins and indirect from specific 
cytokines such as IL-1, IL-6 and TNF [12]. Indeed, it 
has been reported that the PCT threshold of 0.25 
ng/mL to 0.50 ng/mL or a reduction of at least 80% of 
the initial value [13, 14] allows the antibiotic to stop 
earlier without changing the clinical outcome [15-18]. 
The highest PCT values reach 24-48 h after infection, 
and proper management causes the PCT values to 
drop by about 50% within about one to one-half days 
after the infection decoction is interrupted. In some 
clinical cases, interferences with PCT values have 
been introduced, as in patients with renal failure, 
where half-life elimination is prolonged, but PCT 
accumulation does not occur [19]. Data from the 
literature suggests that if stimulation is discontinued 
its concentration decreases progressively and returns 
to baseline values on Day 5 or 7 [20]. An exceptional 
PCT situation is presented if clinical symptoms 
indicate possible sepsis but PCT values are low, then 
sepsis therapy should begin anyway, PCT 
measurement should be repeated (after 12, 24, 36 h) 
until the final diagnosis is clarified [19]. Despite the 
important information, the determination of PCT 
values that have a diagnostic and predictive role in the 
mentioned diagnoses is not yet definitive and is 
considered to be investigated further in other issues of 
surgical infections.  
Indeed, most of the research has evaluated 
PCT's interest in determining the duration of antibiotic 
delivery to conservatively treated patients [9, 11], 
while there is no or insufficient research on the role of 
PCT in intra-abdominal infections diagnosed as 
peritonitis, therefore, the aim of this study is to 
evaluate the predictive role of PCT in the duration of 
antibiotic delivery and treatment priorities based on 
the PCT algorithm in relation to standard treatment. 
 
 
 
Materials and Methods  
 
This is a clinically prospective, controlled trial 
involving hospitalised patients in the Clinical Surgery 
department at University Clinical Hospital of Kosovo in 
Prishtina, registered in the period from March 2016 to 
January 2017. The study was performed with simple 
randomisation, and 100 patients were included out of 
which, 50 patients were used for testing the PCT 
algorithm efficacy in discontinuing antibiotics. The 
study included a control group of 50 patients as a 
comparator in the duration of antibiotic delivery while 
comparing the complications following the 
discontinuation of antibiotics in both groups. The 
Ethics Committee of the University of Prishtina – 
Faculty of Medicine, has approved the research 
protocol and all participants or their family members 
completed the consent form. 
Inclusion and exclusion criteria: Patients over 
the age of 18 diagnosed with acute abdomen with 
Systemic Inflammatory Response Syndrome (SIRS), 
who underwent urgent surgical intervention and Index 
Manheim Peritonitis > 10 points, were eligible for 
enrollment in the study. Patients with a) autoimmune 
disease b) acute hepatic insufficiency c) diabetes d) 
immunosuppression e) pregnant women f) patients 
treated with corticoids g) when the patient or family 
members have refused to be included in the study 
were excluded. 
Protocol and Treatment: PCT levels were 
measured before surgery on the day 1, 4, and 7 and 
the following days as needed. The measurement was 
made with the Elecsys BRAHMS PCT method. The 
restraints of the values measured by this method are 
from 0.02 to 100 ng/mL. Values below the detectable 
limit are reported as < 0.02 ng/mL, whereas those 
over the upper limit are reported >100 ng/mL [21]. 
PCT values in healthy people are low <0.1ng/mL [22]. 
To exclude sepsis and systemic inflammation PCT < 
0.2 ng/mL concentration is a useful reference. As the 
cut off for the diagnosis of sepsis the PCT values > 
0.5 ng/mL are interpreted as abnormal and suggest 
for sepsis [20]. 
Recommendations based on the PCT 
algorithm are discontinuation of the antibiotics when 
PCT decreases > 80% of the initial value or PCT < 0.5 
ng/mL, reduction by the clinical condition and other 
laboratory parameters. 
Antibiotic delivery has begun in all patients 
with acute abdominal symptoms and SIRS presence. 
Interventions have been performed by experienced 
surgeons. After the intervention, all participants 
continued empirically given antibiotics, to the group 
with SIRS/sepsis and severe sepsis ceftriaxone 1 
gram was ordinated intravenously every 12 hours and 
metronidazole 500 mg intravenously every 8 hours, 
while in patients with septic shock imipenem 500 mg 
three times daily and metronidazole 500 mg 
intravenous every 8 hours.  
After receiving the microbiological 
examination results, antibiogram treatment continued. 
Termination of the antibiotics in the study group was 
conducted according to the protocol of the study. The 
basic criteria for the antibiotic discontinuation in 
control group were the normalization of leukocyte 
values followed by improvement of the clinical 
condition. After the antibiotic discontinuation, the 
condition of all patients was monitored for the 
identification of possible complications. 
 
 Mahmutaj et al. The Predictive Role of Procalcitonin On the Treatment of Intra-Abdominal Infections 
_____________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Dec 15; 5(7):909-914.                                                                                                                                                         911 
 
Statistical Analysis 
Stratification of the results was conducted 
based on the criteria of the severity of intraabdominal 
infections (SIRS/sepsis, Severe sepsis, Septic shock). 
We included age, gender, APACHE II, MODS, SOFA 
and INDEX MANNHEIM PERITONITIS. 
The statistical processing of the data was 
conducted with the statistical package SPSS 22.0. 
The arithmetic average, the standard deviation, the 
minimum and the maximum value were calculated 
from statistical parameters. Qualitative data testing 
was done with the 2-test and the exact Fisher test of 
quantitative data that had a normal distribution with T-
test and One Way ANOVA, and those with a 
nonnormal distribution with the Mann-Whitney test or 
Kruskal Wallis test. 
 
 
Results 
 
In both study groups the male patients were 
slightly more than females but without a significant 
statistical difference (X2 = 0.176, P = 0.675). Patients 
of both groups were in different age groups - the 
youngest was 17 years old, and the oldest was 86 
years old. The average age of the patients was 43.2 
years (DS ± 19.5 years), ranging from 17 to 86 years. 
According to the demographic characteristics 
of patients, there is no significant difference between 
the study and control groups. In both groups, 
according to the diagnosis structure, the acute 
perforative appendicitis and perforated duodenal ulcer 
were a more frequent diagnosis of patients. 
The average duration of antibiotic delivery to 
all patients was 11.1 days (SD ± 5.5 days), ranging 
from 3.0 to 31.0 days. In the test group, the average 
duration was 10.6 days (SD ± 6.6 days), ranging from 
3.0 to 31.0 days. In the control group, the average 
duration was 13.2 days (SD ± 4.2 days), ranging from 
3.0 to 29.0 days. With t-test, we revealed significant 
statistical significance (t-test), (P = 0.028), (Table 1). 
Table 1: Characteristics of Patients included in the study 
 Study Group Control Group p 
Age 39.4 ± 19.6 47.0 ± 18.8 0.064a 
Female 16 19 0.675b 
Male 34 31 0.675b 
Etiology of the disease 
Appendicitis acuta perforativa  23 34  
Ulcus bulbi duodeni perforans  9 10  
Perforatio intestini 
(ilei,jejuni,sygmae)  
11 5  
Cholecystitis acuta perforativa  4 1  
St. post op.Wiple (Dehiscencio 
anastomosis pancreatico-jejuni)  
1   
Perforatio diverticulum Meckeli  2   
Duration of Antibiotic Delivery 10.6 ± 6.6 13.2 ± 4.2 0.028c 
Reconnaissance of infection after 
antibiotic termination 
2 (4%) 3 (6%) 
 
 
A = Man Whitney test; b = 2-test; c-T-test. 
 
According to duration of antibiotic 
administration in the study group, we have noted this 
structure of administration: 8% - 4 days, 4% -5 days, 
16% - 6 days, 10% - 7 days, 62% > 7 days. The 
criteria of PCT decreased > 80% of the initial value 
was met in 8 patients; 8 (16%) patients did not receive 
the antibiotics as per PCT < 0.5 ng/mL algorithm. This 
group of patients had an average of 4 days more (SD 
± 3) administered antibiotic due to unsatisfactory 
clinical condition and laboratory parameters, while in 
other 4 patients we had an initial decrease of PCT in < 
0.5 ng/mL, and after that an increase of PCT values. 
Two of these patients had pulmonary problems, and 
the other two were indispensable for reintervention. 
Contrary, in the control group, only 4 (8%) patients 
had antibiotics < 7 days (Table 1). 
Table 2: Duration of Antibiotics Delivery in report to SOFA, 
APACHE II, IMP, MODS, PCT, CRP, WBC in admission of 
patients to the study group 
Abdominal Urgencies (n=50) 
Parameters Septic Shock Severe Sepsis SIRS/Sepsis p 
Duration of 
antibiotic 
administration  
17.0 (SD ± 11.7) 15.9 (SD ± 8.4) 8.6 (SD ± 5.7) 
<0.001
a 
 
SOFA 17.8 (SD ± 7.6) 10.5 (SD ± 3.8) 5.2 (SD ± 2.4) <0.0001
a
 
APACHE II  34 (SD ± 9.5) 19,5 (SD ± 6.3) 9.9 (SD ± 5.1) 
<0.0001
a 
 
MODS 12.8 (SD ± 3.8) 7.3 (SD ± 3.6) 2.3 (SD ± 1.3) <0.184
a
 
PCT 67.8 (SD ± 50.9) 22.5 (SD ± 36.7) 3.7 (SD ± 5.6) 0.00015
a 
CRP  117.9 (SD ± 123.7) 154.2 (SD ± 72.3) 133.1 (SD ± 90.5) 0.431
a
 
WBC 11.5 (SD ± 8.2) 18.4 (SD ± 11.7) 14.2 (SD ± 4.1) 0.132
b
 
a = Kruskal Wallis test; b = one way ANOVA test. 
 
MODS-Multiple Organ Dysfunction Score, 
IMP-Index Mannheim peritonitis, APACHE-Acute 
Physiology and Chronic Health Evaluation, SOFA-
Sequential Organ Failure Assessment, PCT-
procalcitonin, CRP-C reactive protein, TG-
Triglycerides, WBC-White Blood Cell. 
Based on the results we have found a 
significant correlation of the values of SOFA, 
APACHE II, MODS, PCT, and TG with the duration of 
antibiotic delivery, while the values of CRP and WBC 
do not correspond to the duration of antibiotic delivery 
(Table 2). 
 
Figure 1: PCT algorithm according to the severity of the infection 
 
PCT algorithm shows that after surgical 
treatment and initiation of antibiotic therapy in a group 
with SIRS/sepsis and severe sepsis the values are 
reduced until in the septic shock PCT values 
decreases about the initial values but remain high 
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enough to prevent the discontinuation of antibiotics 
(Fig. 1). 
Table 3: Results of microbiological examination in the study 
group and control group 
Microbiological results 
Study Group Control Group Total 
N % N % N % 
Escherichia coli  13 26.0 15 30.0- 28 28.0 
Escherichia coli  
streptococcus pyogenes 
2 4.0 3 6.0 5 5.0 
Escherichia coli  
Pseudomonas aeruginosa 
1 2.0 2 4.0 3 3.0 
Candida SPP 4 8.0 2 4.0 6 6.0 
Klebsiella pneumoniae 4 8.0 2 4.0 6 6.0 
Pseudomonas aeruginosa 5 10.0 2 4.0 7 7.0 
Staphylococcus aureus 2 4.0 3 6.0 5 5.0 
Peptostreptococcus 1 2.0 2 4.0 3 3.0 
Acinetobacter SP 1 2.0 - - 1 1.0 
No culture of bacteria is 
isolated 
17 34.0 19 38.0 36 36.0 
Total 50 100.0 50 100.0 100 100.0 
 
In most of the patients of the study group and 
control group, E. coli in the form of mono-culture or 
co-infection with Streptococcus pyogenes and 
Pseudomonas aeruginosa were isolated. In the 
structure of isolated microorganisms, monocultures of 
Pseudomonas aeruginosa, Klebsiella pneumoniae 
and Candida were also identified microbiological 
cultures. However, the culture of bacteria was not 
isolated in 34.0% of cases in the study group and 38% 
in the control group (Table 3).  
Table 4: Procalcitonin, duration, and types of antibiotics 
according to microbial infection 
Parameters 
Microbiological Infections 
Gram 
positive 
and Gram 
negative 
Gram 
negative 
Gram 
positive 
Mycotic 
Not 
culture 
isolated 
p 
PCT before OP 
(ng/mL) 
4.2 ± 0 18.8 ± 34.6 0.9 ± 0.3 29.5 ± 47.2 3.5 ± 5.2 0.001 
Duration of antibiotic  
delivery (d)  
12 ± 1.4 11.6 ± 5.4 19 ± 16.9 2.5 ± 0.7  0.41 
Metronidazole  2 (5%) 25 (62.5%) 1 (2.5%) 4 (10%) 8 (20%)  
Ceftriaxone - 25 (62.5% 1 (2.5%) 2 (5%) 12 (30%)  
Imipenem and 
enzyme inhibitor  
3 (20%) 6 (40%) 3 (20%) - 3 (20%)  
Gentamicin  1 (100%)     
Tazobactam  1 (100%)     
Lincomycin  2 (50%)   2 (50%)  
Amoxicillin/clavulanic 
acid 
 4 (100%)     
 
The PCT values in the diagnosis structure are 
quite variable with the signaling scale for P < 0.001 
the highest values were recorded in mycotic 
infections, then the gram negative ones, mixed gram 
negative and gram positive infections and even lower 
in gram positive which show a significant statistical 
difference (Table 4). For the treatment of gram 
negative infections, seven different forms of antibiotics 
were administered where Metronidazole and 
Ceftriaxone were dominated, whereas other forms of 
infections were administered with fewer antibiotics. 
 
Discussion 
 
This randomized study evaluated the role of 
PCT algorithm in the duration of antibiotic delivery and 
monitored the success of antibiotics after surgeries of 
intra-abdominal infections with peritonitis. Our findings 
indicate a significant difference in the duration of 
antibiotic delivery between the study group and the 
control group, with a reduction in the duration of 
antibiotic delivery to patients of the study group by 2.6 
days without risking a recurrence of infection. Our 
findings do not correspond to the study conducted by 
Juliette [21], which states that in general there is no 
significant difference in the duration of antibiotic 
delivery between the study group and the control 
group. They revealed the difference by structure of 
pathogenesis of infections, concluding that there is a 
difference in the duration of antibiotic delivery 
between groups of patients with peritonitis due to 
gastrointestinal perforation (7 days in the PCT and 10-
days with control group for p = 0.065), while in 
patients with localized peritonitis and postoperative 
peritonitis caused by intestinal dehiscences, there was 
no reduction of antibiotics with PCT algorithm. 
Other authors have stated that the PCT 
algorithm has a role in reducing the duration of 
antibiotic delivery of peritonitis. Ting Shuo Huang has 
concluded that this algorithm reduces the use of 
antibiotics for three days and provides a 50% relative 
reduction in the duration of antibiotic delivery [22]. 
Also, Schroeder et al. in a comparative study 
with 19 patients with peritonitis after abdominal 
surgery, stated that antibiotics were reduced to the 
research group in relation to the control group in 
significant values (6.6 ± 1.1 days versus 8.3 ± 0.7 
days) [23]. Hochreiter et al. recorded patients with 
confirmed infection or high suspicions for a bacterial 
infection that were treated with antibiotics and were 
hospitalized in Intensive Care [24]. Both authors had 
established antibiotic discontinuity criteria when there 
was clinical improvement and PCT levels < 1.0 ng/mL 
or decreased by 25% to 35% of the initial value within 
three days by making measurements every day. In the 
results of Hochreiter with authors, the duration of 
antibiotic delivery was significantly shorter in 57 
patients compared to the control group 53 patients 
(5.9 ± 1.7 days versus 7.9 ± 0.5 days: p < 0.001) 
without negative effects on results. 
In our study, the discontinuation of the 
antibiotics in the control group was done based on the 
value of the leukocytes and the clinical condition of 
the patients. In our study, measurement was done 
every successive day, and this approach has had an 
impact on the duration of antibiotic delivery. The PCT 
algorithm does not affect the reduction of antibiotics in 
septic shock and severe sepsis. Neither the threshold 
of PCT of 0.5 ng/mL nor the reduction of at least 80% 
of the initial value can accurately predict the response 
to treatment for cases with intra-abdominal infections, 
where there are a septic shock and severe sepsis 
corresponding to the results of other authors [25]. 
Findings of our study show that relation 
between high PCT, TG and high scores of APACHE 
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II, SOFA, IMP, and MODS and antibiotic treatment 
duration, whereas preoperative leukocyte and C – 
reactive protein values do not correspond to the 
duration of antibiotic administration. Other studies 
report that age, hypoalbuminemia, malnutrition, 
comorbidities, APACHE II score ≥ 15 affect the failure 
of management of infection source and the 
appearance of infectious complications [26-28]. 
In the microbiological examination of 
intraperitoneal fluid, our findings indicate that PCT 
values have varied between infection groups and 
have been higher in mycotic infections than in gram-
negative ones, mixed gram negative and positive 
infections, and lower in gram positive infections. 
However, our data regarding mycotic infections do not 
correspond to the findings of other authors Martini et 
al., [29] in his study of 48 surgical patients with 
mycotic infections risk found that the cut off of PCT for 
these infections was 2.0 ng/mL. According to Leli, a 
cut-off of PCT > 1.3 ng/mL can help us in diagnosing 
mycotic infection [30]. Considering that PCT in 
mycotic infections are not usually increased since the 
PCT values are too high in our results, we can 
conclude that these infections are accompanied by 
bacterial infections that have not been detected 
microbiologically in our facilities. In our study PCT cut-
off of 18.8 ng/mL is important for predicting sepsis 
with gram negative bacteria, whereas some studies 
refer to data linking high PCT values with gram 
negative sepsis but with cut off values that differ from 
our values. In the study of Brodská et al. [31], it is 
described that the PCT cut-off of 15 ng/mL can affect 
the sepsis caused by gram negative bacteria from 
sepsis caused by gram positive bacteria and mycotic 
sepsis with 87.8% specificity. While in the study 
conducted by Leli, the findings indicate that the cut-off 
of PCT 10.8 ng/mL may be significant in predicting the 
infection caused by gram-negative bacteria with a 
specificity of 82.5%. Other authors have also found 
that PCT levels were higher in gram negative than in 
gram positive sepsis [32, 33]. In our study, the PCT 
average of sepsis with the gram positive bacteria was 
0.64 ng/mL (SD = 0.3), corresponding to the data of 
the author Shuhua [33], where the PCT value was 
0.48 ng/mL. 
The results from our study and other authors 
suggest that PCT can help in the ordination of proper 
antibacterial initiation therapy, considering that 24-48 
hours should be expected for microbiological results. 
The structure of microorganisms isolated on 
microbiological samples is similar to the results of 
other authors, who reported similar infections of the 
gastrointestinal tract [34, 28]. 
 Overall, we conclude that monitoring of PCT 
value may impact in shortening of treatment antibiotic 
duration in patients with intra-abdominal infections. 
Although PCT is considered to be a very important 
predictive factor in intra-abdominal infections, in the 
presence of clinical signs of sepsis, the role PCT is 
diminished, and antibiotic therapy should be continued 
according to clinical signs and other predictive 
parameters. Also, we conclude that further studies are 
needed to validate the complex role of PCTs in 
antibiotic monitoring through pharmacoepidemio-
logical and pharmacoeconomic studies of antibiotic 
consumption in both groups that would enable 
valuable data to be obtained for the role of this 
algorithm in reducing resistance to antibiotics.  
 
 
References 
1. Marshall JC. Principles of source control in the early 
management of sepsis. Current infectious disease reports. 2010; 
12(5):345–53. https://doi.org/10.1007/s11908-010-0126-z 
PMid:21308516  
2. Grundmann RT, Petersen M, Lippert H, Meyer F. [The acute 
(surgical) abdomen - epidemiology, diagnosis and general 
principles of management]. Zeitschrift fur Gastroenterologie. 2010; 
48(6):696–706. https://doi.org/10.1055/s-0029-1245303 
PMid:20517808  
 
3. Schoeffel U, Jacobs E, Ruf G, Mierswa F, B. von Specht U, 
Farthmann EH. Intraperitoneal micro-organisms and the severity of 
peritonitis. The European journal of surgery = Acta chirurgica. 
1995; 161(7):501–8. 
 
4. Wacha H, Hau T, Dittmer R, Ohmann CP, Peritonitis Study 
Group. Risk factors associated with intraabdominal infections: a 
prospective multicenter study. Langenbeck's archives of surgery. 
1999;384(1):24-32. https://doi.org/10.1007/s004230050169 
PMid:10367626  
 
5. Mulier S, Penninckx F, Verwaest C, Filez L, Aerts R, Fieuws S, 
Lauwers P. Factors affecting mortality in generalized postoperative 
peritonitis: multivariate analysis in 96 patients. World journal of 
surgery. 2003;27(4):379-84. https://doi.org/10.1007/s00268-002-
6705-x PMid:12658477  
 
6. Mazuski JE. Antimicrobial treatment for intra-abdominal 
infections. Expert opinion on pharmacotherapy. 2007;8(17):2933-
45. https://doi.org/10.1517/14656566.8.17.2933 PMid:18001254  
 
7. Adkins AL, Robbins J, Villalba M, Bendick P, Shanley CJ. Open 
abdomen management of intra-abdominal sepsis. Am Surg. 
2004;70(2):137-40. PMid:15011916  
 
8. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, 
Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M. 
Procalcitonin for reduced antibiotic exposure in ventilator-
associated pneumonia: a randomised study. European Respiratory 
Journal. 2009;34(6):1364-75. 
https://doi.org/10.1183/09031936.00053209 PMid:19797133  
 
9. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, 
Tvede M. Procalcitonin increase in early identification of critically ill 
patients at high risk of mortality. Critical care medicine. 
2006;34(10):2596-602. 
https://doi.org/10.1097/01.CCM.0000239116.01855.61 
PMid:16915118  
 
10. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von 
Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic 
therapy in intensive care patients: a randomized prospective 
controlled trial. Critical Care. 2009;13(3):R83. 
https://doi.org/10.1186/cc7903 PMid:19493352 
PMCid:PMC2717450 
 
11. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, 
Bohuon CL. Procalcitonin increase after endotoxin injection in 
normal subjects. The Journal of Clinical Endocrinology & 
Metabolism. 1994;79(6):1605-8. PMid:7989463  
 
12. Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, 
Keck FS, Von Spiegel T. Procalcitonin (PCT)-guided algorithm  
Clinical Science 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
  914                                                                                                                                                                                                                     http://www.mjms.mk/ 
http://www.id-press.eu/mjms/ 
 
reduces length of antibiotic treatment in surgical intensive care 
patients with severe sepsis: results of a prospective randomized 
study. Langenbeck's archives of surgery. 2009;394(2):221-6. 
https://doi.org/10.1007/s00423-008-0432-1 PMid:19034493  
13. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin 
algorithms for antibiotic therapy decisions: a systematic review of 
randomized controlled trials and recommendations for clinical 
algorithms. Archives of internal medicine. 2011;171(15):1322-31. 
https://doi.org/10.1001/archinternmed.2011.318 PMid:21824946  
 
14. Schuetz P, et al, Procalcitonin to initiate or discontinue 
antibiotics in acute respiratory tract infections. Cochrane Database 
of Systematic Reviews. 2012; (9):CD007498. 
https://doi.org/10.1002/14651858.CD007498.pub2 
 
15. Agarwal R, Schwartz DN. Procalcitonin to guide duration of 
antimicrobial therapy in intensive care units: a systematic review. 
Clinical Infectious Diseases. 2011;53(4):379-87. 
https://doi.org/10.1093/cid/cir408 PMid:21810753  
 
16. Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis 
A. Procalcitonin-guided algorithms of antibiotic therapy in the 
intensive care unit: a systematic review and meta-analysis of 
randomized controlled trials. Critical care medicine. 
2010;38(11):2229-41. 
https://doi.org/10.1097/CCM.0b013e3181f17bf9 PMid:20729729  
 
17. Rau BM, Frigerio I, Büchler MW, Wegscheider K, Bassi C, 
Puolakkainen PA, Beger HG, Schilling MK. Evaluation of 
procalcitonin for predicting septic multiorgan failure and overall 
prognosis in secondary peritonitis: a prospective, international 
multicenter study. Archives of Surgery. 2007;142(2):134-42. 
https://doi.org/10.1001/archsurg.142.2.134 PMid:17309964  
 
18. Meisner M. Update on procalcitonin measurements. Annals of 
laboratory medicine. 2014;34(4):263-73. 
https://doi.org/10.3343/alm.2014.34.4.263 PMid:24982830 
PMCid:PMC4071182 
 
19. Meisner M, Tschaikowsky K, Schnabel S, Schmidt J, Katalinic 
A, Schüttler J. Procalcitonin-influence of temperature, storage, 
anticoagulation and arterial or venous asservation of blood 
samples on procalcitonin concentrations. Clinical Chemistry and 
Laboratory Medicine. 1997;35(8):597-602. 
https://doi.org/10.1515/cclm.1997.35.8.597 
 
20. Omar AS, ElShawarby A, Singh R. Early monitoring of 
ventriculostomy-related infections with procalcitonin in patients with 
ventricular drains. Journal of clinical monitoring and computing. 
2015;29(6):759-65. https://doi.org/10.1007/s10877-015-9663-1 
PMid:25638513  
 
21. Slieker JC, Aellen S, Eggimann P, Guarnero V, Schäfer M, 
Demartines N. Procalcitonin-Guided Antibiotics after Surgery for 
Peritonitis: A Randomized Controlled Study. Gastroenterology 
Research and Practice. 2017;2017. 
 
22. Huang TS, Huang SS, Shyu YC, Lee CH, Jwo SC, Chen PJ, 
Chen HY. A procalcitonin-based algorithm to guide antibiotic 
therapy in secondary peritonitis following emergency surgery: a 
prospective study with propensity score matching analysis. PloS 
one. 2014;9(3):e90539. 
https://doi.org/10.1371/journal.pone.0090539 PMid:24594916 
PMCid:PMC3942439 
 
23. Schroeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B, 
Keck FS, Von Spiegel T. Procalcitonin (PCT)-guided algorithm 
reduces length of antibiotic treatment in surgical intensive care 
patients with severe sepsis: results of a prospective randomized 
study. Langenbeck's archives of surgery. 2009;394(2):221-6. 
https://doi.org/10.1007/s00423-008-0432-1 PMid:19034493  
 
24. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, von 
Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic 
therapy in intensive care patients: a randomized prospective 
controlled trial. Critical Care. 2009;13(3):R83. 
https://doi.org/10.1186/cc7903 PMid:19493352 
PMCid:PMC2717450 
 
25. Jung B, Molinari N, Nasri M, Hajjej Z, Chanques G, Jean-Pierre 
H, Panaro F, Jaber S. Procalcitonin biomarker kinetics fails to 
predict treatment response in perioperative abdominal infection 
with septic shock. Critical Care. 2013;17(5):R255. 
https://doi.org/10.1186/cc13082 PMid:24156734 
PMCid:PMC4056026 
 
26. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein 
EJ, Baron EJ, O'neill PJ, Chow AW, Dellinger EP, Eachempati SR, 
Gorbach S. Diagnosis and management of complicated intra-
abdominal infection in adults and children: guidelines by the 
Surgical Infection Society and the Infectious Diseases Society of 
America. Clinical infectious diseases. 2010;50(2):133-64. 
https://doi.org/10.1086/649554 PMid:20034345  
 
27. Hennessey DB, Burke JP, Ni-Dhonochu T, Shields C, Winter 
DC, Mealy K. Preoperative hypoalbuminemia is an independent 
risk factor for the development of surgical site infection following 
gastrointestinal surgery: a multi-institutional study. Annals of 
surgery. 2010;252(2):325-9. 
https://doi.org/10.1097/SLA.0b013e3181e9819a PMid:20647925  
 
28. Hakansson A, Molin G. Gut microbiota and inflammation. 
Nutrients. 2011;3(6):637-82. https://doi.org/10.3390/nu3060637 
PMid:22254115 PMCid:PMC3257638 
 
29. Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, 
Vincent JL. Procalcitonin levels in surgical patients at risk of 
candidemia. Journal of Infection. 2010;60(6):425-30. 
https://doi.org/10.1016/j.jinf.2010.03.003 PMid:20226210  
 
30. Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci 
A. Procalcitonin levels in gram-positive, gram-negative, and fungal 
bloodstream infections. Disease markers. 2015;2015. 
 
31. Brodská H, Malíčková K, Adámková V, Benáková H, Šťastná 
MM, Zima T. Significantly higher procalcitonin levels could 
differentiate Gram-negative sepsis from Gram-positive and fungal 
sepsis. Clinical and experimental medicine. 2013;13(3):165-70. 
https://doi.org/10.1007/s10238-012-0191-8 PMid:22644264  
 
32. Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S, 
Olsson NO, Blettery B. Serum procalcitonin elevation in critically ill 
patients at the onset of bacteremia caused by either Gram negative 
or Gram positive bacteria. BMC infectious diseases. 2008;8(1):38. 
https://doi.org/10.1186/1471-2334-8-38 PMid:18366777 
PMCid:PMC2289831 
 
33. Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum 
procalcitonin levels distinguish Gram-negative bacterial sepsis from 
Gram-positive bacterial and fungal sepsis. Journal of research in 
medical sciences: the official journal of Isfahan University of 
Medical Sciences. 2016;21. 
 
34. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, 
Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D. Duration of 
hypotension before initiation of effective antimicrobial therapy is the 
critical determinant of survival in human septic shock. Critical care 
medicine. 2006;34(6):1589-96. 
https://doi.org/10.1097/01.CCM.0000217961.75225.E9 
PMid:16625125  
 
 
